PMMR
Clinical trials for PMMR explained in plain language.
Never miss a new study
Get alerted when new PMMR trials appear
Sign up with your email to follow new studies for PMMR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new combo aims to control advanced rectal cancer
Disease control Recruiting nowThis study tests a new treatment approach for people with rectal cancer that has spread to a limited number of other organs (called oligometastases). The treatment combines short-course radiation, chemotherapy, and an immunotherapy drug called serplulimab. The goal is to see if t…
Matched conditions: PMMR
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 17, 2026 03:12 UTC
-
New triple therapy aims to shrink hard-to-treat rectal cancers before surgery
Disease control Recruiting nowThis study tests whether combining an immunotherapy drug (serplulimab) with chemotherapy (CAPEOX) and an anti-inflammatory drug (celecoxib) can shrink advanced rectal cancers before surgery. The trial enrolls 50 adults with a specific type of rectal cancer (pMMR/MSS) that usually…
Matched conditions: PMMR
Phase: PHASE2 • Sponsor: Zhejiang University • Aim: Disease control
Last updated May 15, 2026 11:54 UTC